Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 140
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Physiol Pharmacol ; 70(6)2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32203940

RESUMEN

Streptozotocin (STZ) is commonly used to induce diabetes mellitus in experimental animal studies on peripheral diabetic neuropathy (PDN). Animals with STZ model of diabetes commonly develop changes in test stimulus-evoked pain behavior. However, it is still unclear whether rats with STZ model of diabetes have ongoing pain. Here we assessed whether STZ-induced diabetes induces ongoing pain-like behavior in male rats using conditioned place-preference (CPP) paradigm. CPP was tested in the fourth week of diabetes by pairing one chamber of the CPP device with vehicle and another chamber with either pregabalin (an established analgesic; 30 mg/kg i.p.; n = 9) or Chembridge-5861528 (a TRPA1 channel antagonist; 30 mg/kg i.p.; n = 9). After drug-pairings, the animals were allowed to choose which chamber they preferred. Mechanical sensitivity was assessed with monofilaments and chemonociception in the skin by determining mustard oil-induced pain behavior. Diabetic animals developed in two weeks mechanical hypersensitivity that changed into hyposensitivity by the fourth week. Mustard oil-induced sustained pain was reduced by the 4th week. After 4 weeks of diabetes, neither pregabalin nor the TRPA1 antagonist induced a significant overall change in the median CPP, although both drugs significantly reduced median withdrawal responses evoked by noxious mechanical stimulation. Pregabalin-induced CPP, however, had a significant positive correlation with the sustained pain behaviour induced by topical mustard oil. In conclusion, the present results suggest that the response to topical mustard oil may predict ongoing pain-like behavior in the STZ model of diabetes.


Asunto(s)
Diabetes Mellitus Experimental/fisiopatología , Neuropatías Diabéticas/fisiopatología , Dolor/fisiopatología , Analgésicos/farmacología , Animales , Condicionamiento Psicológico/fisiología , Modelos Animales de Enfermedad , Masculino , Planta de la Mostaza/toxicidad , Aceites de Plantas/toxicidad , Pregabalina/farmacología , Ratas , Ratas Wistar , Estreptozocina , Canal Catiónico TRPA1/antagonistas & inhibidores
2.
Physiol Res ; 67(4): 647-655, 2018 08 16.
Artículo en Inglés | MEDLINE | ID: mdl-29750883

RESUMEN

Here we studied whether descending control of mechanical nociception by glutamate in the central nucleus of the amygdala (CeA) of healthy control animals is induced by amygdaloid NMDA receptors and relayed through the midbrain periaqueductal gray (PAG). Mechanical nociception in the hind paws was assessed in rats with chronic guide cannulae for glutamate administration in the right CeA and for inducing local anesthesia in the PAG. In a separate electrophysiological study, ON-like PAG neurons giving an excitatory response to noxious pinch of the tail were recorded in anesthetized rats following glutamate administration into the CeA. A high dose of glutamate (100 microg) in the CeA induced mechanical antinociception in the contra- but not ipsilateral hind limb. Antinociception was prevented by an NMDA receptor antagonist in the CeA or local anesthesia of the PAG. Discharge rate of ON-like PAG neurons was increased by a high dose of glutamate (100 microg) in the CeA and this increase was prevented by an NMDA receptor antagonist in the CeA. The results indicate that amygdaloid NMDA receptors in the CeA may induce contralaterally mechanical antinociception through a circuitry relaying in the PAG. Activation of ON-like PAG neurons is associated with the descending antinociceptive effect. Mechanisms and causality of this association still remain to be studied.


Asunto(s)
Núcleo Amigdalino Central/fisiología , Red Nerviosa/fisiología , Dimensión del Dolor/métodos , Dolor/fisiopatología , Sustancia Gris Periacueductal/fisiología , Animales , Núcleo Amigdalino Central/efectos de los fármacos , Antagonistas de Aminoácidos Excitadores/farmacología , Antagonistas de Aminoácidos Excitadores/uso terapéutico , Ácido Glutámico/toxicidad , Masculino , Red Nerviosa/efectos de los fármacos , Dolor/inducido químicamente , Dolor/prevención & control , Dimensión del Dolor/efectos de los fármacos , Sustancia Gris Periacueductal/efectos de los fármacos , Ratas , Ratas Wistar
3.
Neuroscience ; 387: 92-103, 2018 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-29274353

RESUMEN

Earlier studies indicate that the central nucleus of the amygdala (CeA) contributes to neuropathic pain. Here we studied whether amygdaloid administration of antioxidants or antagonists of TRPA1 that is among ion channels activated by oxidative stress attenuates nociceptive or affective pain in experimental neuropathy, and whether this effect involves amygdaloid astrocytes or descending serotonergic pathways acting on the spinal 5-HT1A receptor. The experiments were performed in rats with spared nerve injury (SNI). Drugs were administered through a chronic cannula in the CeA or internal capsule (control site), and an intrathecal catheter. Nociception was assessed using monofilaments and affective pain using conditioned place-aversion. Antioxidants or TRPA1 antagonists in the CeA attenuated both nociceptive and affective pain in SNI animals but not in sham controls or in a control injection site. Drugs influencing astroglia (a gap junction decoupler or a D-amino acid oxidase inhibitor) in the CeA had no effect on SNI rats, whereas local anesthesia of the CeA attenuated nociception. Spinally administered 5-HT1A receptor antagonist at a dose that had no effect alone prevented the antinociceptive effect of amygdaloid TRPA1 blockers. The results suggest that injury-induced amygdaloid oxidative stress that drives TRPA1 promotes neuropathic pain behavior. This pronociceptive effect involves suppression of medullospinal serotonergic feedback-inhibition acting on the spinal 5-HT1A receptor. While the CeA is involved in mediating the nerve injury-induced pronociception, it may not be a critical relay for the recruitment of medullospinal feedback-inhibition.


Asunto(s)
Amígdala del Cerebelo/metabolismo , Neuralgia/metabolismo , Estrés Oxidativo , Amígdala del Cerebelo/efectos de los fármacos , Animales , Carbenoxolona/farmacología , Condicionamiento Psicológico/efectos de los fármacos , Óxidos N-Cíclicos/farmacología , Cápsula Interna/efectos de los fármacos , Lidocaína/farmacología , Masculino , Microinyecciones , Neuralgia/prevención & control , Estrés Oxidativo/efectos de los fármacos , Oximas/farmacología , Dimensión del Dolor/efectos de los fármacos , Traumatismos de los Nervios Periféricos , Piperazinas/farmacología , Pirazoles/farmacología , Piridinas/farmacología , Ratas , Antagonistas del Receptor de Serotonina 5-HT1/farmacología , Marcadores de Spin , terc-Butilhidroperóxido/farmacología
4.
Eur J Pain ; 21(9): 1505-1515, 2017 10.
Artículo en Inglés | MEDLINE | ID: mdl-28493519

RESUMEN

BACKGROUND: Repetitive transcranial magnetic stimulation (rTMS) at M1/S1 cortex has been shown to alleviate neuropathic pain. OBJECTIVES: To investigate the possible neurobiological correlates of cortical neurostimulation for the pain relief. METHODS: We studied the effects of M1/S1 rTMS on nociception, brain dopamine D2 and µ-opioid receptors using a randomized, sham-controlled, double-blinded crossover study design and 3D-positron emission tomography (PET). Ten healthy subjects underwent active and sham rTMS treatments to the right M1/S1 cortex with E-field navigated device. Dopamine D2 and µ-receptor availabilities were assessed with PET radiotracers [11 C]raclopride and [11 C]carfentanil after each rTMS treatment. Thermal quantitative sensory testing (QST), contact heat evoked potential (CHEP) and blink reflex (BR) recordings were performed between the PET scans. RESULTS: µ-Opioid receptor availability was lower after active than sham rTMS (P ≤ 0.0001) suggested release of endogenous opioids in the right ventral striatum, medial orbitofrontal, prefrontal and anterior cingulate cortices, and left insula, superior temporal gyrus, dorsolateral prefrontal cortex and precentral gyrus. There were no differences in striatal dopamine D2 receptor availability between active and sham rTMS, consistent with lack of long-lasting measurable dopamine release. Active rTMS potentiated the dopamine-regulated habituation of the BR compared to sham (P = 0.02). Thermal QST and CHEP remained unchanged after active rTMS. CONCLUSIONS: rTMS given to M1/S1 activates the endogenous opioid system in a wide brain network associated with processing of pain and other salient stimuli. Direct enhancement of top-down opioid-mediated inhibition may partly explain the clinical analgesic effects of rTMS. SIGNIFICANCE: Neurobiological correlates of rTMS for the pain relief are unclear. rTMS on M1/S1 with 11 C-carfentanyl-PET activates endogenous opioids. Thermal and heat pain thresholds remain unchanged. rTMS induces top-down opioid-mediated inhibition but not change the sensory discrimination of painful stimuli.


Asunto(s)
Corteza Cerebral/metabolismo , Péptidos Opioides/metabolismo , Manejo del Dolor , Dolor/metabolismo , Tomografía de Emisión de Positrones , Estimulación Magnética Transcraneal/métodos , Adulto , Corteza Cerebral/diagnóstico por imagen , Estudios Cruzados , Femenino , Humanos , Masculino , Dolor/diagnóstico por imagen , Dimensión del Dolor , Umbral del Dolor/fisiología , Receptores de Dopamina D2/metabolismo , Receptores Opioides mu/metabolismo , Adulto Joven
5.
J Physiol Pharmacol ; 67(4): 587-594, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27779479

RESUMEN

Methylglyoxal (MG) is a reactive carbonyl compound generated in diabetes mellitus. MG is an established transient receptor potential ankyrin 1 (TRPA1) channel agonist that contributes to TRPA1-mediated diabetic pain hypersensitivity. Here we studied whether exposure to diabetes and thereby to elevated endogenous MG modulates hypersensitivity induced by intradermal MG. Moreover, since diabetes induces endoplasmic reticulum (ER) stress, we compared the role of TRPA1 in diabetes and ER stress by assessing whether tunicamycin-induced ER stress, without diabetes, produces TRPA1-mediated pain hypersensitivity and by assessing whether ER stress and diabetes have similar modulatory effects on MG-induced hypersensitivity. In vitro patch clamp recording was performed to assess whether tunicamycin is a TRPA1 agonist. Behavioral tests showed that mechanical hypersensitivity induced by MG is reduced in diabetes and ER stress. In healthy controls, hypersensitivity induced by MG was reduced when MG was administered for the second time in the same but not adjacent plantar sites. Hypersensitivity induced by ER stress was reversed by pharmacological blocking of TRPA1. In vitro patch clamp recording indicated that tunicamycin itself (30 µM) is not a TRPA1 agonist. The results indicate that pain hypersensitivity induced by non-diabetic ER stress as well as that induced by diabetes is mediated TRPA1. Reduction of MG-induced hypersensitivity in diabetes or ER stress may, at least partly, be explained by peripheral mechanisms.


Asunto(s)
Estrés del Retículo Endoplásmico/efectos de los fármacos , Hiperalgesia/inducido químicamente , Piruvaldehído/farmacología , Canales Catiónicos TRPC/agonistas , Tunicamicina/farmacología , Administración Cutánea , Animales , Conducta Animal/efectos de los fármacos , Diabetes Mellitus Experimental , Células HEK293 , Humanos , Masculino , Dimensión del Dolor , Estimulación Física , Ratas , Piel/efectos de los fármacos , Canal Catiónico TRPA1 , Canales Catiónicos TRPC/fisiología
6.
Neuroscience ; 312: 108-19, 2016 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-26548413

RESUMEN

The involvement of the prefrontal cortex in pain processing has been recently addressed. We studied the role of the infralimbic cortex (IL) and group I metabotropic glutamate receptors (mGluRs) in descending modulation of nociception in control and monoarthritic (ARTH) conditions. Nociception was assessed using heat-induced paw withdrawal while drugs were microinjected in the IL of rats. Local anesthesia of the IL or the adjacent prelimbic cortex (PL) facilitated nociception, indicating that IL and PL are tonically promoting spinal antinociception. Phasic activation with glutamate (GLU) revealed opposing roles of the PL and IL; GLU in the PL had a fast antinociceptive action, while in the IL it had a slow onset pronociceptive action. IL administration of a local anesthetic or GLU produced identical results in ARTH and control animals. An mGluR5 agonist in the IL induced a pronociceptive effect in both groups, while mGluR5 antagonists had no effect in controls but induced antinociception in ARTH rats. Activation of the IL mGluR1 (through co-administration of mGluR1/5 agonist and mGluR5 antagonist) did not alter nociception in controls but induced antinociception in ARTH animals. IL administration of an mGluR1 antagonist failed to alter nociception in either experimental group. Finally, mGluR5 but not mGluR1 antagonists blocked the pronociceptive action of GLU in both groups. The results indicate that IL contributes to descending modulation of nociception. mGluR5 in the IL enhance nociception in healthy control and monoarthritic animals, an effect that is tonic in ARTH. Moreover, activation of IL mGluR1s attenuates nociception following the development of monoarthritis.


Asunto(s)
Artritis/fisiopatología , Ácido Glutámico/fisiología , Hiperalgesia/fisiopatología , Nocicepción/fisiología , Corteza Prefrontal/fisiología , Receptor del Glutamato Metabotropico 5/fisiología , Animales , Modelos Animales de Enfermedad , Masculino , Nocicepción/efectos de los fármacos , Corteza Prefrontal/efectos de los fármacos , Ratas , Ratas Wistar , Receptor del Glutamato Metabotropico 5/agonistas , Receptor del Glutamato Metabotropico 5/antagonistas & inhibidores
7.
Behav Brain Res ; 282: 14-24, 2015 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-25557801

RESUMEN

Amygdala is involved in processing of primary emotions and particularly its central nucleus (CeA) also in pain control. Here we studied mechanisms mediating the descending control of mechanical hypersensitivity by the CeA in rats with a peripheral neuropathy in the left hind limb. For drug administrations, the animals had a guide cannula in the right CeA and an intrathecal catheter or another guide cannula in the medullary raphe. Hypersensitivity was tested with monofilaments. Glutamate administration in the CeA produced a bidirectional effect on hypersensitivity that varied from an increase at a low-dose (9µg) to a reduction at high doses (30-100µg). The increase but not the reduction of hypersensitivity was prevented by blocking the amygdaloid NMDA receptor with a dose of MK-801 that alone had no effects. The glutamate-induced increase in hypersensitivity was reversed by blocking the spinal 5-HT3 receptor with ondansetron, whereas the reduction in hypersensitivity was reversed by blocking the spinal 5-HT1A receptor with WAY-100635. Both the increase and decrease of hypersensitivity induced by amygdaloid glutamate treatment were reversed by medullary administration of a 5-HT1A agonist, 8-OH-DPAT, that presumably produced autoinhibition of serotonergic cell bodies in the medullary raphe. The results indicate that depending on the dose, glutamate in the CeA has a descending facilitatory or inhibitory effect on neuropathic pain hypersensitivity. Serotoninergic raphe neurons are involved in mediating both of these effects. Spinally, the 5-HT3 receptor contributes to the increase and the 5-HT1A receptor to the decrease of neuropathic hypersensitivity induced by amygdaloid glutamate.


Asunto(s)
Amígdala del Cerebelo/metabolismo , Neuralgia/metabolismo , Enfermedades del Sistema Nervioso Periférico/metabolismo , Receptor de Serotonina 5-HT1A/metabolismo , Receptores de Serotonina 5-HT3/metabolismo , Médula Espinal/metabolismo , 8-Hidroxi-2-(di-n-propilamino)tetralin/farmacología , Amígdala del Cerebelo/efectos de los fármacos , Animales , Maleato de Dizocilpina/farmacología , Ácido Glutámico/farmacología , Masculino , Ondansetrón/farmacología , Dimensión del Dolor/métodos , Piperazinas/farmacología , Piridinas/farmacología , Ratas , Ratas Wistar , Receptores de N-Metil-D-Aspartato/agonistas , Receptores de N-Metil-D-Aspartato/antagonistas & inhibidores , Agonistas del Receptor de Serotonina 5-HT1/farmacología , Antagonistas del Receptor de Serotonina 5-HT1/farmacología , Agonistas del Receptor de Serotonina 5-HT3/farmacología , Antagonistas del Receptor de Serotonina 5-HT3/farmacología , Médula Espinal/efectos de los fármacos
8.
Behav Brain Res ; 265: 12-21, 2014 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-24518202

RESUMEN

Affective disorders are common comorbidities of chronic inflammatory pain that are often overlooked in primary care. As the impact of inflammatory pain upon mood-like disorders in animal models is not well known, our objective was to assess whether prolonged experimental monoarthritis (ARTH) induced the development of anxiety and depressive-like behaviours in rodents and if amitriptyline, an antidepressant commonly used in the treatment of chronic pain, could reverse both nociceptive and mood-like impairments. Experimental ARTH was induced through an injection of kaolin/carrageenan into the right knee joint with control (SHAM) animals injected with saline. Four weeks after induction, ARTH animals displayed mechanical hyperalgesia and a depressive-like phenotype as they showed a significant increase in immobility and a decrease in the latency to immobility in the forced-swimming test at the expense of the time spent climbing/swimming. ARTH animals also displayed a decreased sucrose preference, an index of anhedonia and anxiety-like behaviour as time spent exploring the open arms of the elevated-plus-maze was decreased when compared to controls. The anxiety-like phenotype was also supported by an increase in the number of fecal boli left in the open field. In ARTH animals, the administration of amitriptyline decreased mechanical hyperalgesia and increased sucrose preference and the time spent climbing, although it had a deleterious effect in the performance of control animals. Our data show that this model of ARTH can be useful for the study of chronic pain-mood disorders comorbidities and that amitriptyline is able to partly reverse the associated nociceptive and emotional impairments.


Asunto(s)
Amitriptilina/farmacología , Amitriptilina/uso terapéutico , Analgésicos no Narcóticos/uso terapéutico , Artritis/complicaciones , Hiperalgesia/tratamiento farmacológico , Trastornos del Humor/tratamiento farmacológico , Trastornos del Humor/etiología , Animales , Artritis/inducido químicamente , Carragenina/farmacología , Modelos Animales de Enfermedad , Conducta Exploratoria/efectos de los fármacos , Preferencias Alimentarias/efectos de los fármacos , Hiperalgesia/etiología , Caolín/farmacología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Umbral del Dolor/efectos de los fármacos , Estimulación Física/efectos adversos , Ratas , Ratas Wistar , Natación/psicología
9.
Neuroscience ; 253: 426-34, 2013 Dec 03.
Artículo en Inglés | MEDLINE | ID: mdl-24036376

RESUMEN

The neurobiological mechanisms of spinal cord stimulation (SCS) when applied for neuropathic pain are still incompletely known. Previous research indicates that brainstem circuitry is pivotal for the SCS effect. The present study aims at exploring the possible contribution to the SCS effects of the pain controlling system emanating from the locus coeruleus (LC) in the brain stem. Experiments were performed on the rat-spared nerve injury pain model. After evaluation of the attenuation of mechanical hypersensitivity induced by SCS, the effects of SCS on neuronal activity in the LC and on the noradrenaline (NA) content in the dorsal spinal cord were analyzed. SCS produced a significant increase in the discharge rate of LC neurons only in rats behaviorally responding to SCS as compared to non-responding and control animals. The NA content in the dorsal quadrant of the spinal cord ipsilateral to the nerve injury was analyzed using enzyme-linked immunosorbent assay in responding, non-responding and intact control rats both immediately following SCS and without SCS. No differences were found between these groups. In awake animals, lidocaine silencing of the ipsilateral LC or blocking of spinal noradrenergic system by intrathecal administration of α1,2 adrenoceptor antagonists failed to influence the antihypersensitivity effect of SCS. The present results indicate that the SCS-induced control of hypersensitivity in an experimental animal model of peripheral neuropathic pain may not be explained by the activation of direct spinal projections of noradrenergic LC neurons, while supraspinal projections of LC neurons still may play a role in the SCS effect.


Asunto(s)
Estimulación Eléctrica , Locus Coeruleus/patología , Neuronas/fisiología , Ciática/terapia , Médula Espinal/fisiología , Potenciales de Acción/efectos de los fármacos , Antagonistas de Receptores Adrenérgicos alfa 1/farmacología , Antagonistas de Receptores Adrenérgicos alfa 2/farmacología , Anestésicos Locales/farmacología , Animales , Modelos Animales de Enfermedad , Hiperalgesia/fisiopatología , Hiperalgesia/terapia , Imidazoles/farmacología , Lidocaína/farmacología , Locus Coeruleus/efectos de los fármacos , Masculino , Vías Nerviosas/efectos de los fármacos , Vías Nerviosas/fisiología , Neuronas/efectos de los fármacos , Umbral del Dolor/fisiología , Estimulación Física/efectos adversos , Prazosina/farmacología , Ratas , Ratas Wistar
10.
J Physiol Pharmacol ; 64(3): 331-40, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23959730

RESUMEN

We characterized pain behavior and cutaneous blood flow response induced by activation of the spinal transient receptor potential ankyrin 1 (TRPA1) channel using intrathecal drug administrations in the rat. Additionally, we assessed whether the pronociceptive actions induced by intrathecally administered dynorphin A, cholecystokinin or prostaglandin F(2α) are mediated by the spinal TRPA1 channel. Cinnamaldehyde, a TRPA1 agonist, produced a dose-related (3-10 µg) cutaneous blood flow increase and mechanical hypersensitivity effect. These effects at the currently used doses were of short duration and attenuated, although not completely, by pretreatment with A-967079, a TRPA1 antagonist. The cinnamaldehyde-induced hypersensitivity was also reduced by pretreatment with minocycline (an inhibitor of microglial activation), but not by carbenoxolone (a gap junction decoupler). In vitro study, however, indicated that minocycline only poorly blocks the TRPA1 channel. The mechanical hypersensitivity effect induced by dynorphin A, but not that by cholecystokinin or prostaglandin F(2α), was attenuated by a TRPA1 antagonist Chembridge-5861528 as well as A-967079. The cinnamaldehyde-induced cutaneous blood flow increase was not suppressed by MK-801, an NMDA receptor antagonist, or bicuculline, a GABA(A) receptor antagonist. The results indicate that spinal TRPA1 channels promote mechanical pain hypersensitivity and due to antidromic activation of nociceptive nerve fibers increase cutaneous blood flow. The attenuation of the cinnamaldehyde-induced hypersensitivity effect by minocycline may be explained by action other than block of the TRPA1 channel. Moreover, the spinal TRPA1 channel is involved in mediating the pronociceptive action of dynorphin A, but not that of the spinal cholecystokinin or prostaglandin F(2α).


Asunto(s)
Analgésicos no Narcóticos/uso terapéutico , Dolor de Espalda/tratamiento farmacológico , Dinorfinas/antagonistas & inhibidores , Hiperalgesia/tratamiento farmacológico , Células del Asta Posterior/efectos de los fármacos , Piel/efectos de los fármacos , Canales Catiónicos TRPC/antagonistas & inhibidores , Acroleína/administración & dosificación , Acroleína/efectos adversos , Acroleína/análogos & derivados , Acroleína/antagonistas & inhibidores , Analgésicos no Narcóticos/administración & dosificación , Animales , Dolor de Espalda/etiología , Dolor de Espalda/metabolismo , Conducta Animal/efectos de los fármacos , Colecistoquinina/administración & dosificación , Colecistoquinina/antagonistas & inhibidores , Colecistoquinina/metabolismo , Dinoprost/administración & dosificación , Dinoprost/antagonistas & inhibidores , Dinoprost/metabolismo , Relación Dosis-Respuesta a Droga , Dinorfinas/administración & dosificación , Dinorfinas/metabolismo , Hiperalgesia/inducido químicamente , Hiperalgesia/metabolismo , Inyecciones Espinales , Masculino , Minociclina/administración & dosificación , Minociclina/uso terapéutico , Proteínas del Tejido Nervioso/agonistas , Proteínas del Tejido Nervioso/antagonistas & inhibidores , Proteínas del Tejido Nervioso/metabolismo , Oximas/administración & dosificación , Oximas/uso terapéutico , Estimulación Física/efectos adversos , Células del Asta Posterior/metabolismo , Ratas , Ratas Wistar , Flujo Sanguíneo Regional/efectos de los fármacos , Piel/irrigación sanguínea , Canal Catiónico TRPA1 , Canales Catiónicos TRPC/agonistas , Canales Catiónicos TRPC/metabolismo
11.
Neuroscience ; 247: 134-44, 2013 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-23711584

RESUMEN

The neurobiological mechanisms underlying the suppression of neuropathic pain by spinal cord stimulation (SCS) are still incompletely known. The present study aims at exploring whether the descending pain control system in the rostroventromedial medulla (RVM) exerts a role in the attenuation of neuropathic pain by SCS. Experiments were performed in the rat spared nerve injury (SNI) pain model. The effects of SCS on neuronal activity of pronociceptive ON-like, antinociceptive OFF-like, and neutral cells, including 5-HT-like cells, in the RVM were analyzed in SCS responding and SCS non-responding SNI animals as well as in naïve controls. Decreased spontaneous activities in OFF-like cells and increased spontaneous activities in ON-like cells were observed in SNI animals, whereas the spontaneous activities of 5-HT-like and neutral cells were unchanged. SCS produced a prominent increase in the discharge of OFF- and 5-HT-like cells in SCS responding, but not in non-responding SNI animals or controls. Discharge rates of ON-like and neutral cell were not affected by SCS. In awake SNI animals, microinjection of a GABAA receptor agonist, muscimol, into the RVM significantly attenuated the antihypersensitivity effect induced by SCS while a non-selective opioid receptor antagonist, naltrexone, was ineffective. It is concluded that SCS may shift the reciprocal inhibitory and facilitatory pain modulation balance controlled by the RVM in favor of inhibition. This increase in the descending antinociceptive effect operates in concert with segmental spinal mechanisms in producing pain relief.


Asunto(s)
Bulbo Raquídeo/fisiología , Neuralgia/terapia , Manejo del Dolor/métodos , Dimensión del Dolor/métodos , Estimulación de la Médula Espinal/métodos , Animales , Masculino , Vías Nerviosas/fisiología , Neuralgia/fisiopatología , Ratas , Ratas Wistar , Resultado del Tratamiento
12.
Genes Brain Behav ; 11(5): 513-23, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22435671

RESUMEN

Fragile X syndrome (FXS) is a common cause of inherited intellectual disability and a well-characterized form of autism spectrum disorder. As brain-derived neurotrophic factor (BDNF) is implicated in the pathophysiology of FXS we examined the effects of reduced BDNF expression on the behavioral phenotype of an animal model of FXS, Fmr1 knockout (KO) mice, crossed with mice carrying a deletion of one copy of the Bdnf gene (Bdnf(+/-)). Fmr1 KO mice showed age-dependent alterations in hippocampal BDNF expression that declined after the age of 4 months compared to wild-type controls. Mild deficits in water maze learning in Bdnf(+/-) and Fmr1 KO mice were exaggerated and contextual fear learning significantly impaired in double transgenics. Reduced BDNF expression did not alter basal nociceptive responses or central hypersensitivity in Fmr1 KO mice. Paradoxically, the locomotor hyperactivity and deficits in sensorimotor learning and startle responses characteristic of Fmr1 KO mice were ameliorated by reducing BNDF, suggesting changes in simultaneously and in parallel working hippocampus-dependent and striatum-dependent systems. Furthermore, the obesity normally seen in Bdnf(+/-) mice was eliminated by the absence of fragile X mental retardation protein 1 (FMRP). Reduced BDNF decreased the survival of newborn cells in the ventral part of the hippocampus both in the presence and absence of FMRP. Since a short neurite phenotype characteristic of newborn cells lacking FMRP was not found in cells derived from double mutant mice, changes in neuronal maturation likely contributed to the behavioral phenotype. Our results show that the absence of FMRP modifies the diverse effects of BDNF on the FXS phenotype.


Asunto(s)
Factor Neurotrófico Derivado del Encéfalo/genética , Trastornos del Conocimiento/genética , Proteína de la Discapacidad Intelectual del Síndrome del Cromosoma X Frágil/genética , Trastornos Neurológicos de la Marcha/genética , Hipercinesia/genética , Animales , Conducta Animal , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Células Cultivadas , Trastornos del Conocimiento/metabolismo , Condicionamiento Psicológico/fisiología , Miedo/fisiología , Proteína de la Discapacidad Intelectual del Síndrome del Cromosoma X Frágil/metabolismo , Trastornos Neurológicos de la Marcha/metabolismo , Hipocampo/metabolismo , Hipercinesia/metabolismo , Aprendizaje por Laberinto/fisiología , Ratones , Ratones Noqueados , Actividad Motora/genética , Células-Madre Neurales , Neuronas/metabolismo , Reflejo de Sobresalto/genética
13.
Br J Pharmacol ; 161(7): 1553-65, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20726980

RESUMEN

BACKGROUND AND PURPOSE: Catechol-O-methyltransferase (COMT) inhibitors are used in Parkinson's disease in which pain is an important symptom. COMT polymorphisms modulate pain and opioid analgesia in humans. In rats, COMT inhibitors have been shown to be pro-nociceptive in acute pain models, but also to attenuate allodynia and hyperalgesia in a model of diabetic neuropathy. Here, we have assessed the effects of acute and repeated administrations of COMT inhibitors on mechanical, thermal and carrageenan-induced nociception in male mice. EXPERIMENTAL APPROACH: We used single and repeated administration of a peripherally restricted, short-acting (nitecapone) and also a centrally acting (3,5-dinitrocatechol, OR-486) COMT inhibitor. We also tested CGP 28014, an indirect inhibitor of COMT enzyme. Effects of OR-486 on thermal nociception were also studied in COMT deficient mice. Effects on spinal pathways were assessed in rats given intrathecal nitecapone. KEY RESULTS: After single administration, both nitecapone and OR-486 reduced mechanical nociceptive thresholds and thermal nociceptive latencies (hot plate test) at 2 and 3 h, regardless of their brain penetration. These effects were still present after chronic treatment with COMT inhibitors for 5 days. Intraplantar injection of carrageenan reduced nociceptive latencies and both COMT inhibitors potentiated this reduction without modifying inflammation. CGP 28014 shortened paw flick latencies. OR-486 did not modify hot plate times in Comt gene deficient mice. Intrathecal nitecapone modified neither thermal nor mechanical nociception. CONCLUSIONS AND IMPLICATIONS: Pro-nociceptive effects of COMT inhibitors were confirmed. The pro-nociceptive effects were primarily mediated via mechanisms acting outside the brain and spinal cord. COMT protein was required for these actions.


Asunto(s)
Inhibidores de Catecol O-Metiltransferasa , Catecol O-Metiltransferasa/metabolismo , Inhibidores Enzimáticos/farmacología , Nociceptores/fisiología , Umbral del Dolor/efectos de los fármacos , Dolor/inducido químicamente , Animales , Conducta Animal/efectos de los fármacos , Catecol O-Metiltransferasa/genética , Catecoles/administración & dosificación , Catecoles/farmacología , Inhibidores Enzimáticos/administración & dosificación , Hiperalgesia/inducido químicamente , Hiperalgesia/fisiopatología , Inflamación/inducido químicamente , Inflamación/fisiopatología , Inyecciones Espinales , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Dolor/fisiopatología , Dimensión del Dolor , Pentanonas/administración & dosificación , Pentanonas/farmacología , Ratas , Ratas Wistar , Factores de Tiempo
14.
Neuroscience ; 167(4): 1175-82, 2010 Jun 02.
Artículo en Inglés | MEDLINE | ID: mdl-20298759

RESUMEN

Memantine is a low-affinity NMDA receptor antagonist that is used in the treatment of Alzheimer's disease to alleviate the cognitive symptoms of the disease. In humans, memantine has been shown to facilitate auditory change detection as reflected in the mismatch negativity (MMN) response recorded in the frontal cortex. In the present study we investigated the effects of memantine on the auditory MMN-like responses recorded in anesthetized rats. Saline, a low (3 mg/kg) or a high (10 mg/kg) dose of memantine was i.p. injected into the animals. Auditory MMN-like responses were recorded during the presentation of a repeated tone of one frequency (standard, P=0.956) that was rarely replaced by a tone of another frequency (deviant, P=0.044). The low dose of memantine did not observably affect the amplitude of the auditory MMN-like response, but it prolonged the duration of the response relative to saline. The high dose of memantine, in contrast, blocked the generation of the auditory MMN-like response. The findings suggest that memantine may, with appropriate doses, facilitate already this early stage of auditory processing.


Asunto(s)
Potenciales Evocados Auditivos/efectos de los fármacos , Memantina/farmacología , Receptores de N-Metil-D-Aspartato/antagonistas & inhibidores , Estimulación Acústica , Anestesia , Animales , Corteza Auditiva/efectos de los fármacos , Corteza Auditiva/fisiología , Variación Contingente Negativa/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Masculino , Ratas
15.
Neuroscience ; 146(4): 1785-94, 2007 Jun 08.
Artículo en Inglés | MEDLINE | ID: mdl-17445989

RESUMEN

Noradrenergic locus coeruleus (LC) is involved in pain regulation. We studied whether response properties of LC neurons or coeruleospinal antinociception are changed 10-14 days following development of experimental neuropathy. Experiments were performed in spinal nerve-ligated, sham-operated and unoperated male rats under sodium pentobarbital anesthesia. Recordings of LC neurons indicated that responses evoked by noxious somatic stimulation were enhanced in nerve-injured animals, while the effects of nerve injury on spontaneous activity or the response to noxious visceral stimulation were not significant. Microinjection of glutamate into the central nucleus of the amygdala produced a dose-related inhibition of the discharge rate of LC neurons in nerve-injured animals but no significant effect on discharge rates in control groups. Assessment of the heat-induced hind limb withdrawal latency indicated that spinal antinociception induced by electrical stimulation of the LC was significantly weaker in nerve-injured than control animals. The results indicate that peripheral neuropathy induces bidirectional changes in coeruleospinal inhibition of pain. Increased responses of LC neurons to noxious somatic stimulation are likely to promote feedback inhibition of neuropathic hypersensitivity, while the enhanced inhibition of the LC from the amygdala is likely to suppress noradrenergic pain inhibition and promote neuropathic pain. It is proposed that the decreased spinal antinociception induced by direct stimulation of the LC may be explained by pronociceptive changes in the non-noradrenergic systems previously described in peripheral neuropathy. Furthermore, we propose the hypothesis that emotions processed by the amygdala enhance pain due to increased inhibition of the LC in peripheral neuropathy.


Asunto(s)
Hiperalgesia/etiología , Locus Coeruleus/patología , Neuronas/fisiología , Enfermedades del Sistema Nervioso Periférico/complicaciones , Potenciales de Acción/fisiología , Animales , Conducta Animal , Relación Dosis-Respuesta en la Radiación , Vías Eferentes/fisiopatología , Estimulación Eléctrica/métodos , Lateralidad Funcional/fisiología , Ácido Glutámico/farmacología , Locus Coeruleus/efectos de la radiación , Masculino , Neuronas/efectos de los fármacos , Neuronas/efectos de la radiación , Dimensión del Dolor/métodos , Enfermedades del Sistema Nervioso Periférico/patología , Ratas , Ratas Wistar , Tiempo de Reacción/fisiología , Tiempo de Reacción/efectos de la radiación
16.
Neuroscience ; 134(3): 1023-32, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16039797

RESUMEN

The mammalian RFamide-related peptide RFRP1 was found to signal through the neuropeptide FF 2 receptor expressed in Xenopus oocytes. The peptide induced a dose-dependent outward current, which was dependent on the simultaneous expression of GIRK1 and GIRK4 potassium channels. In neuropathic rats, RFRP1 administered intrathecally induced tactile antiallodynia and thermal antinociception, whereas in the solitary tract nucleus it produced only mechanical antihyperalgesia. Expression of the RFamide-related peptide mRNA in the rat CNS was distinctly different from that of neuropeptide FF. Most notably, the gene was not expressed in the hindbrain or spinal cord at detectable levels. However, there was a prominent group of RFamide-related peptide mRNA-expressing neurons in the central hypothalamus, in the area in and between the dorsomedial and ventromedial nuclei. The results suggest that RFamide-related peptides are potentially involved in pain regulation through a hypothalamo-medullary projection system, and possibly via action on neuropeptide FF 2 receptors. In neuropathic animals, the pain suppressive effect of RFamide-related peptide varies depending on the submodality of noxious test stimulation and the site of RFamide-related peptide administration.


Asunto(s)
Neuropéptidos/administración & dosificación , Dolor/tratamiento farmacológico , Receptores de Neuropéptido/fisiología , Transducción de Señal/fisiología , Animales , Clonación Molecular/métodos , Relación Dosis-Respuesta a Droga , Canales de Potasio Rectificados Internamente Asociados a la Proteína G , Humanos , Hibridación in Situ/métodos , Masculino , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Potenciales de la Membrana/efectos de la radiación , Microinyecciones/métodos , Neuropéptidos/farmacología , Dolor/fisiopatología , Dimensión del Dolor/métodos , Umbral del Dolor/efectos de los fármacos , Canales de Potasio de Rectificación Interna/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Tiempo de Reacción/efectos de los fármacos , Núcleo Solitario/efectos de los fármacos , Núcleo Solitario/fisiopatología , Médula Espinal/efectos de los fármacos , Médula Espinal/fisiopatología , Xenopus laevis
17.
Neuroscience ; 114(3): 655-68, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12220567

RESUMEN

We studied the effect of chemical sympathectomy by 6-hydroxydopamine (6-OHDA) on pain behavior and alpha(2)-adrenergic antinociception in rats with a spinal nerve ligation-induced neuropathy. For assessment of alpha(2)-adrenergic antinociception, the rats were treated systemically with two alpha(2)-adrenoceptor agonists, one of which only poorly (MPV-2426) and the other very well (dexmedetomidine) penetrates the blood-brain barrier. Moreover, the effect of MPV-2426 on spontaneous activity of dorsal root nerve fibers proximal to the nerve injury was determined. Systemic treatment with 6-OHDA produced a marked decrease in immunocytochemical labeling of sympathetic nerve fibers in the skin but it produced no marked change in basal pain sensitivity to mechanical stimulation either in neuropathic or sham-operated animals. Systemic administration of MPV-2426 and dexmedetomidine produced a dose-dependent tactile antiallodynic effect in neuropathic animals. Intraplantar injection of MPV-2426 had an identical antiallodynic effect independent of whether it was injected into the neuropathic or contralateral hindpaw. In a test of mechanical nociception and hyperalgesia, dexmedetomidine markedly attenuated pain responses in all experimental groups, whereas MPV-2426 had a weak but significant pain attenuating effect only in neuropathic animals. In the tail flick test, both alpha(2)-adrenoceptor agonists had a significant antinociceptive effect. The pain attenuating effect of MPV-2426 was enhanced by pretreatment with 6-OHDA, except in a test of tactile allodynia. MPV-2426-induced modulation of spontaneous activity was not a general property of dorsal root fibers proximal to the injury. The results indicate that a chemical destruction of sympathetic postganglionic nerve fibers innervating the skin does not markedly influence cutaneous pain sensitivity nor is it critical for the alpha(2)-adrenoceptor agonist-induced attenuation of pain behavior in neuropathic or non-neuropathic animals. Chemical sympathectomy, independent of neuropathy, enhanced the pain attenuating effect by MPV-2426, probably due to a peripheral action, whereas in non-sympathectomized control and neuropathic animals peripheral mechanisms have only a minor, if any, role in the alpha(2)-adrenoceptor agonist-induced antinociception.


Asunto(s)
Agonistas de Receptores Adrenérgicos alfa 2 , Agonistas alfa-Adrenérgicos/farmacología , Analgésicos/farmacología , Dimensión del Dolor/efectos de los fármacos , Simpatectomía Química , Animales , Conducta Exploratoria/efectos de los fármacos , Conducta Exploratoria/fisiología , Imidazoles/farmacología , Indanos/farmacología , Ligadura , Masculino , Dimensión del Dolor/métodos , Dimensión del Dolor/estadística & datos numéricos , Ratas , Ratas Wistar , Receptores Adrenérgicos alfa 2/fisiología , Nervios Espinales/lesiones , Simpatectomía Química/métodos , Simpatectomía Química/estadística & datos numéricos , Fibras Simpáticas Posganglionares/efectos de los fármacos , Fibras Simpáticas Posganglionares/fisiología
18.
Neuroscience ; 113(2): 339-49, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12127091

RESUMEN

The purpose of the present study was to investigate the role of mu-opioid receptor in inflammatory hyperalgesia in intact and in spinalized animals and the interaction between mu-opioid and alpha2-adrenergic receptor in acute pain and inflammatory hyperalgesia. Behavioral responses to mechanical and heat stimuli were studied in mu-opioid receptor knockout mice and wildtype control mice. Thermal nociception was evaluated by measuring paw withdrawal latencies to radiant heat applied to the hindpaws. Mechanical nociception was measured by von Frey monofilament applications to the hindpaws. Intraplantar carrageenan-induced (1 mg/40 microl) mechanical and heat hyperalgesia were compared in micro-opioid knockout and wildtype mice. The effect of systemically administered alpha2-adrenergic receptor agonist dexmedetomidine (1-10 microg/kg) was evaluated on mechanical and thermal withdrawal responses under normal and inflammatory state in knockout and wildtype mice. The role of micro-opioid receptor in descending modulation of nociception was studied by assessing mechanical and heat withdrawal responses before and after mid-thoracic spinalization. Withdrawal responses to radiant heat and von Frey monofilaments were similar in mu-opioid knockout and wildtype mice before and after the carrageenan induced hindpaw inflammation. Also, antinociceptive effects of dexmedetomidine in thermal and mechanical nociceptive tests were similar before carrageenan induced hindpaw inflammation. However, the potency of dexmedetomidine was significantly reduced in carrageenan-induced mechanical hyperalgesia in mu-opioid knockout mice compared to the wildtype control mice. Thermal and mechanical withdrawal responses were similar between mu-opioid knockout and wildtype mice before and after mid-thoracic spinalization. Our observations indicate that the mu-opioid receptors do not play an important role in alpha2-adrenergic receptor agonist-mediated acute antinociception. In addition, micro-opioid receptors are not tonically involved in the modulation of inflammation-induced mechanical and thermal hyperalgesia, and the supraspinal control of spinal reflexes. However, in the presence of inflammation, mu-opioid receptors play an important role in the antihyperalgesic actions of an alpha2-adrenergic receptor agonist.


Asunto(s)
Hiperalgesia/etiología , Hiperalgesia/fisiopatología , Inflamación/complicaciones , Receptores Adrenérgicos alfa/fisiología , Receptores Opioides mu/fisiología , Agonistas alfa-Adrenérgicos/farmacología , Antagonistas Adrenérgicos alfa/farmacología , Animales , Carragenina , Estado de Descerebración , Dexmedetomidina/farmacología , Pie , Miembro Posterior , Calor , Imidazoles/farmacología , Inflamación/inducido químicamente , Ratones , Ratones Noqueados/genética , Nociceptores/efectos de los fármacos , Estimulación Física , Receptores Opioides mu/genética , Valores de Referencia
19.
Eur J Pharmacol ; 429(1-3): 139-45, 2001 Oct 19.
Artículo en Inglés | MEDLINE | ID: mdl-11698036

RESUMEN

We studied the contribution of peripheral opioid receptors to the morphine-induced antinociception in rats with a spinal nerve ligation-induced neuropathy. Intraplantar (i.pl.) injection of morphine produced a stronger suppression of nociceptive reflex responses of the neuropathic limb following ipsilateral, than contralateral, administration, whereas the morphine-induced effect on the control limb was independent of the injection side. Antinociception induced by systemically administered morphine was significantly attenuated by i.pl. injection of a peripherally acting opioid receptor antagonist in neuropathic but not in sham-operated rats. Following chemical sympathectomy with 6-hydroxydopamine, antinociception was achieved at a lower dose ipsilaterally, than contralaterally, following i.pl. administration of morphine, and the morphine-induced antinociception was attenuated by a peripherally acting opioid receptor antagonist. These results indicate that peripheral opioid receptors may contribute to the morphine-induced antinociception in the spinal nerve ligation-induced model of neuropathy. Sympathectomy of the neuropathic limb may underlie, at least partly, the increased peripheral efficacy of morphine in neuropathy.


Asunto(s)
Analgésicos Opioides/administración & dosificación , Mononeuropatías/tratamiento farmacológico , Morfina/administración & dosificación , Fibras Simpáticas Posganglionares/efectos de los fármacos , Fibras Simpáticas Posganglionares/fisiología , Animales , Miembro Posterior , Inyecciones Subcutáneas , Ligadura , Masculino , Mononeuropatías/inducido químicamente , Oxidopamina , Dimensión del Dolor/efectos de los fármacos , Ratas , Ratas Wistar , Receptores Opioides/fisiología , Nervios Espinales/efectos de los fármacos , Nervios Espinales/fisiología , Simpaticolíticos
20.
Neuroscience ; 105(2): 457-68, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11672611

RESUMEN

We determined whether chronic neuropathy changes response properties of neurons in the rostroventromedial medulla of rats, and whether (d-Tyr)L(Me-Phe)QPQRF-amide, a neuropeptide FF analogue, in the periaqueductal gray produces changes in responses of rostroventromedial medullary neurons that might underlie its antiallodynic effect described earlier. Single unit recordings of medullary neurons were performed in lightly anesthetized neuropathic and control animals. Spontaneous activity and the responses to noxious thermal and mechanical stimulation of the hind paw were determined with and without administration of (d-Tyr)L(Me-Phe)QPQRF-amide. The neurons were classified into three groups: ON-neurons increased, OFF-neurons decreased, and NEUTRAL-neurons did not change their discharge rate prior to a limb withdrawal induced by noxious stimulation of the skin. Spontaneous activity and heat-evoked responses of ON-neurons were not different between neuropathic and control animals, whereas their mechanically evoked responses were reduced in neuropathy. Response properties of OFF-neurons were not different between neuropathic and control animals. Spontaneous activity of NEUTRAL-neurons was not different between neuropathic and control animals. (d-Tyr)L(Me-Phe)QPQRF-amide in the periaqueductal gray had no significant effect on evoked responses or spontaneous activity of ON- or OFF-neurons, independent of the experimental group. However, (d-Tyr)L(Me-Phe)QPQRF-amide produced a significant attenuation of spontaneous activity of NEUTRAL-neurons in neuropathic animals. In a behavioral study performed in unanesthetized animals it was found that intrathecal administration of methysergide, a serotonin antagonist, selectively attenuated neuropathic symptoms. Also, light pentobarbitone anesthesia markedly attenuated, but did not abolish, behaviorally determined neuropathic symptoms. From these results we suggest that NEUTRAL-neurons of the rostroventromedial medulla may have a role in neuropathy and they may be involved in attenuation of mechanical hypersensitivity by (d-Tyr)L(Me-Phe)QPQRF-amide in the periaqueductal gray. It is proposed that in neuropathy the synaptic effects of descending impulses from medullary NEUTRAL-neurons on their axonal targets in the spinal cord are changed so that this contributes to mechanical hypersensitivity, due to mechanisms that are at least partly serotoninergic.


Asunto(s)
Potenciales de Acción/fisiología , Medios de Contraste/farmacología , Bulbo Raquídeo/metabolismo , Neuralgia/metabolismo , Oligopéptidos/farmacología , Núcleos del Rafe/metabolismo , Formación Reticular/metabolismo , Potenciales de Acción/efectos de los fármacos , Adyuvantes Anestésicos/farmacología , Animales , Hiperalgesia/metabolismo , Hiperalgesia/patología , Hiperalgesia/fisiopatología , Ligadura , Masculino , Bulbo Raquídeo/citología , Bulbo Raquídeo/efectos de los fármacos , Metisergida/farmacología , Vías Nerviosas/citología , Vías Nerviosas/efectos de los fármacos , Vías Nerviosas/metabolismo , Neuralgia/patología , Neuralgia/fisiopatología , Oligopéptidos/metabolismo , Dimensión del Dolor/efectos de los fármacos , Pentobarbital/farmacología , Sustancia Gris Periacueductal/citología , Sustancia Gris Periacueductal/efectos de los fármacos , Sustancia Gris Periacueductal/metabolismo , Enfermedades del Sistema Nervioso Periférico/metabolismo , Enfermedades del Sistema Nervioso Periférico/patología , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Estimulación Física , Núcleos del Rafe/citología , Núcleos del Rafe/efectos de los fármacos , Ratas , Ratas Wistar , Tiempo de Reacción/efectos de los fármacos , Tiempo de Reacción/fisiología , Formación Reticular/citología , Formación Reticular/efectos de los fármacos , Serotonina/metabolismo , Antagonistas de la Serotonina/farmacología , Nervios Espinales/lesiones , Nervios Espinales/fisiopatología , Nervios Espinales/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...